Associated Papers
Association between inherited thrombophilia and venous thromboembolism in patients with non-O blood type: a meta-analysis.
Pomero F et al.
Polish Archives of Internal Medicine, 2022
Genetic variation of the blood coagulation regulator tissue factor pathway inhibitor and venous thromboembolism among middle-aged and older adults: A population-based cohort study.
Manderstedt E et al.
Research and Practice in Thrombosis and Haemostasis, 2022
Endothelin-1 Gene Polymorphism and Its Level Predict the Risk of Venous Thromboembolism in Male Indian Population.
Kumari B et al.
Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/hemostasis, 2017
Association of genetic polymorphisms with plasma TFPI level: Boon or curse for DVT patients - Study from India.
Kamal K et al.
Blood Cells, Molecules & Diseases, 2017
A Prothrombotic Score Based on Genetic Polymorphisms of the Hemostatic System Differs in Patients with Ischemic Stroke, Myocardial Infarction, or Peripheral Arterial Occlusive Disease.
Herm J et al.
Frontiers in Cardiovascular Medicine, 2017
Genetic susceptibility to deep venous thromboembolism: the roles of inherited thrombophilia polymorphisms.
Bargahi N et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis, 2016
Association between genetic polymorphisms and deep vein thrombosis in a Chinese population.
Jiang J et al.
Thrombosis Research, 2015
Genetic determinants of tissue factor pathway inhibitor plasma levels.
Dennis J et al.
Thrombosis and Haemostasis, 2015
Study of associated genetic variants in Indian subjects reveals the basis of ethnicity related differences in susceptibility to venous thromboembolism.
Kumari B et al.
Thrombosis, 2014
Boy with pseudohypoparathyroidism type 1a caused by GNAS gene mutation (deltaN377), Crouzon-like craniosynostosis, and severe trauma-induced bleeding.
Graul-Neumann LM et al.
American Journal of Medical Genetics. Part A, 2009
Association analysis of tissue factor pathway inhibitor polymorphisms and haplotypes with osteonecrosis of the femoral head in the Korean population.
Dai XL et al.
Molecules and Cells, 2008
Proof of principle of potential clinical utility of multiple SNP analysis for prediction of recurrent venous thrombosis.
van Hylckama Vlieg A et al.
Journal of Thrombosis and Haemostasis : Jth, 2008
Lack of association between thrombosis-associated and cytokine candidate gene polymorphisms and acute rejection or vascular complications after kidney transplantation.
Alakulppi NS et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 2008
An interactive association of common sequence variants in the neuropeptide Y gene with susceptibility to ischemic stroke.
Lee C et al.
Stroke, 2007
An unfavorable combination of Factor V Leiden with age, weight, and blood group causes high risk of pregnancy-associated venous thrombosis: a population-based nested case-control study.
Hiltunen L et al.
Thrombosis Research, 2007
Genetics of coagulation: considerations for cardiac surgery.
Morozowich ST et al.
Seminars in Cardiothoracic and Vascular Anesthesia, 2006
Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population.
Hoppe B et al.
Thrombosis and Haemostasis, 2006
Functional polymorphisms of FGA, encoding alpha fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population.
Ko YL et al.
Human Genetics, 2006
Analysis of sequence variations in the promoter region of the human tissue factor pathway inhibitor 2 gene in apoplectic patients and blood donors.
Siegling S et al.
Annals of Hematology, 2006
Prothrombotic factors in children with stroke or porencephaly.
Lynch JK et al.
Pediatrics, 2005
A locus on chromosome 2 influences levels of tissue factor pathway inhibitor: results from the GAIT study.
Almasy L et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2005
The tissue factor pathway inhibitor C536T mutation is not associated with the risk of stroke in young adults.
Junker R et al.
Thrombosis and Haemostasis, 2002
Prevalence of the C536T mutation in the tissue factor pathway inhibitor (TFPI) gene among patients with venous thromboembolic disease.
Paciaroni K et al.
Thrombosis and Haemostasis, 2001